Literature DB >> 23093376

Induction and inhibition of crystallization in drug-in-adhesive-type transdermal patches.

Piyush Jain1, Ajay K Banga.   

Abstract

PURPOSE: To screen crystallization inhibitors, perform accelerated stability testing and predict saturation solubility of levonorgestrel in drug-in-adhesive patches.
METHODS: Differential scanning calorimetry (DSC) studies were compared against slide crystallization studies for screening additives. Release studies were performed from crystallized and supersaturated patches. Die cutting was used for accelerated stability testing of patches. Time lag experiments were performed to predict saturation solubility of levonorgestrel in acrylate adhesive, DuroTak-2516.
RESULTS: DSC studies indicated poloxamer to be the best additive whereas slide crystallization studies showed polyvinylpyrrolidone to be better. Supersaturated patches showed higher release profiles relative to crystallized patches. Crystals were observed in crystallized patches even after 96 h of release studies. Die-cutting of patches helped in development of crystals in less time as compared to uncut sheets indicating its usefulness in accelerated stability testing. Saturation solubility of levonorgestrel in DuroTak-2516 was predicted to be 0.09% w/w which was in close agreement with value of 0.1% w/w from solubility calculator on vendor's website.
CONCLUSIONS: Crystallization was shown to have negative impact on drug release and patch performance. Slide crystallization studies, die cutting and time lag experiments can be used as tools to help stabilize the otherwise unstable patches.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23093376     DOI: 10.1007/s11095-012-0901-7

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  18 in total

1.  Influence of adsorbents in transdermal matrix patches on the release and the physical state of ethinyl estradiol and levonorgestrel.

Authors:  Martin Schulz; Bernhard Fussnegger; Roland Bodmeier
Journal:  Eur J Pharm Biopharm       Date:  2010-11-30       Impact factor: 5.571

2.  Impact of antinucleants on transdermal delivery of testosterone from a spray.

Authors:  Marie-Laure Leichtnam; Hervé Rolland; Patrick Wüthrich; Richard H Guy
Journal:  J Pharm Sci       Date:  2007-01       Impact factor: 3.534

3.  Formulation study of oxybutynin patches.

Authors:  Paola Minghetti; Francesco Cilurzo; Stefania Pagani; Antonella Casiraghi; Riccardo Assandri; Luisa Montanari
Journal:  Pharm Dev Technol       Date:  2007       Impact factor: 3.133

4.  Effect of casting solvent on crystallinity of ondansetron in transdermal films.

Authors:  Satyanarayan Pattnaik; Kalpana Swain; Subrata Mallick; Zhiqun Lin
Journal:  Int J Pharm       Date:  2011-01-13       Impact factor: 5.875

5.  In vitro release of levonorgestrel from phase sensitive and thermosensitive smart polymer delivery systems.

Authors:  Sibao Chen; Jagdish Singh
Journal:  Pharm Dev Technol       Date:  2005       Impact factor: 3.133

6.  Eudragits: role as crystallization inhibitors in drug-in-adhesive transdermal systems of estradiol.

Authors:  P N Kotiyan; P R Vavia
Journal:  Eur J Pharm Biopharm       Date:  2001-09       Impact factor: 5.571

7.  Manipulation of corticosteroid release from a transiently supersaturated topical metered dose aerosol using a residual miscible co-solvent.

Authors:  Monica L Reid; Marc B Brown; Stuart A Jones
Journal:  Pharm Res       Date:  2008-07-31       Impact factor: 4.200

8.  Crystallization of hydrocortisone acetate: influence of polymers.

Authors:  S L Raghavan; A Trividic; A F Davis; J Hadgraft
Journal:  Int J Pharm       Date:  2001-01-16       Impact factor: 5.875

9.  Polymorphism of 17-beta estradiol in a transdermal drug delivery system.

Authors:  N E Variankaval; K I Jacob; S M Dinh
Journal:  J Mater Sci Mater Med       Date:  2002-03       Impact factor: 3.896

Review 10.  Passive transdermal systems whitepaper incorporating current chemistry, manufacturing and controls (CMC) development principles.

Authors:  Glenn A Van Buskirk; Daniel Arsulowicz; Prabir Basu; Lawrence Block; Bing Cai; Gary W Cleary; Tapash Ghosh; Mario A González; David Kanios; Margareth Marques; Patrick K Noonan; Terrance Ocheltree; Peter Schwarz; Vinod Shah; Thomas S Spencer; Lino Tavares; Katherine Ulman; Rajendra Uppoor; Thean Yeoh
Journal:  AAPS PharmSciTech       Date:  2012-01-04       Impact factor: 3.246

View more
  4 in total

Review 1.  Transdermal patches: history, development and pharmacology.

Authors:  Michael N Pastore; Yogeshvar N Kalia; Michael Horstmann; Michael S Roberts
Journal:  Br J Pharmacol       Date:  2015-03-18       Impact factor: 8.739

2.  Formulation and evaluation of 4-benzylpiperidine drug-in-adhesive matrix type transdermal patch.

Authors:  Sindhu S Ganti; Sonalika A Bhattaccharjee; Kevin S Murnane; Bruce E Blough; Ajay K Banga
Journal:  Int J Pharm       Date:  2018-08-17       Impact factor: 5.875

3.  Design and Evaluation of a Poly(Lactide-co-Glycolide)-Based In Situ Film-Forming System for Topical Delivery of Trolamine Salicylate.

Authors:  Yujin Kim; Moritz Beck-Broichsitter; Ajay K Banga
Journal:  Pharmaceutics       Date:  2019-08-12       Impact factor: 6.321

4.  Microscopic and Spectroscopic Imaging and Thermal Analysis of Acrylates, Silicones and Active Pharmaceutical Ingredients in Adhesive Transdermal Patches.

Authors:  Barbara Mikolaszek; Marzena Jamrógiewicz; Krystyna Mojsiewicz-Pieńkowska; Małgorzata Sznitowska
Journal:  Polymers (Basel)       Date:  2022-07-16       Impact factor: 4.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.